Delivery Order SPE2DR25D1106-SPE2DR26FJD4P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, valued at $1,807.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,293.41 on November 25, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml quantities. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a contract ceiling value of $2,401.91. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, executed without a set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL) with a ceiling value of $1,431.19. This is a firm fixed-price, non-set-aside delivery order that will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in a 180 mL quantity, with a contract value of $1,313.05 and a completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen Drug Corp's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a ceiling value of $1,809.72. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, valued at $2,638.27. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in a 60 mL quantity, with a ceiling value of $1,968.69. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.78 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (60 ml) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD4PDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, with a ceiling value of $3,053.76. This is a firm fixed-price delivery order executed under a non-competitive, no set-aside classification. The order is scheduled for completion by December 12, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health System, delivering a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical uses this IDC structure to efficiently procure pharmaceuticals and medical supplies globally in support of military healthcare operations, with the company's firm fixed-price delivery orders demonstrating consistent capability to meet federal procurement requirements across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/10/25 |